Strain identifier

BacDive ID: 1682

Type strain: Yes

Species: Bifidobacterium adolescentis

Strain Designation: E194a (Variant a), E194a

Strain history: CIP <- 1964, Lab. Ident. Inst. Pasteur, Paris, France <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain E194a

NCBI tax ID(s): 367928 (strain), 1680 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 8.1 (current version)

General

@ref: 8510

BacDive-ID: 1682

DSM-Number: 20083

keywords: genome sequence, 16S sequence, Bacteria, anaerobe, mesophilic, human pathogen

description: Bifidobacterium adolescentis E194a is an anaerobe, mesophilic human pathogen that was isolated from intestine of adult.

NCBI tax id

NCBI tax idMatching level
367928strain
1680species

strain history

@refhistory
8510<- ATCC <- G. Reuter, E194a (Variant a)
67770ATCC 15703 <-- G. Reuter E194a (Variant a).
116048CIP <- 1964, Lab. Ident. Inst. Pasteur, Paris, France <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain E194a

doi: 10.13145/bacdive1682.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Bifidobacteriales
  • family: Bifidobacteriaceae
  • genus: Bifidobacterium
  • species: Bifidobacterium adolescentis
  • full scientific name: Bifidobacterium adolescentis Reuter 1963 (Approved Lists 1980)
  • synonyms

    • @ref: 20215
    • synonym: Bifidobacterium stercoris

@ref: 8510

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Bifidobacteriales

family: Bifidobacteriaceae

genus: Bifidobacterium

species: Bifidobacterium adolescentis

full scientific name: Bifidobacterium adolescentis Reuter 1963 emend. Nouioui et al. 2018

strain designation: E194a (Variant a), E194a

type strain: yes

Morphology

cell morphology

@refmotilityconfidencegram staincell shape
69480no90.27
69480100positive
116048nopositiverod-shaped

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
8510BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58)yeshttps://mediadive.dsmz.de/medium/58Name: BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) Composition: Glucose 10.0 g/l Casein peptone 10.0 g/l Bacto Soytone 5.0 g/l Meat extract 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l MnSO4 x H2O 0.05 g/l KH2PO4 0.04 g/l K2HPO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Tween 80 Resazurin Distilled water
32787MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)
116048CIP Medium 20yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=20
116048CIP Medium 72yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72

culture temp

@refgrowthtypetemperaturerange
8510positivegrowth37mesophilic
32787positivegrowth37mesophilic
67770positivegrowth37mesophilic

Physiology and metabolism

oxygen tolerance

@refoxygen toleranceconfidence
8510anaerobe
69480anaerobe99.686
116048anaerobe

spore formation

@refspore formationconfidence
69481no100
69480no99.988

murein

  • @ref: 8510
  • murein short key: A11.32
  • type: A4alpha L-Lys(L-Orn)-D-Asp

metabolite utilization

@refmetaboliteutilization activitykind of utilization testedChebi-ID
68371Potassium 2-ketogluconate-builds acid from
68371L-arabitol-builds acid from18403
68371D-arabitol-builds acid from18333
68371L-fucose-builds acid from18287
68371D-fucose-builds acid from28847
68371D-tagatose-builds acid from16443
68371D-lyxose-builds acid from62318
68371xylitol-builds acid from17151
68371glycogen-builds acid from28087
68371starch-builds acid from28017
68371raffinose+builds acid from16634
68371melezitose-builds acid from6731
68371sucrose+builds acid from17992
68371melibiose+builds acid from28053
68371lactose+builds acid from17716
68371esculin+builds acid from4853
68371arbutin+builds acid from18305
68371methyl alpha-D-glucopyranoside+builds acid from320061
68371myo-inositol-builds acid from17268
68371galactitol-builds acid from16813
68371L-rhamnose-builds acid from62345
68371D-fructose+builds acid from15824
68371D-glucose+builds acid from17634
68371D-galactose+builds acid from12936
68371methyl beta-D-xylopyranoside-builds acid from74863
68371ribitol-builds acid from15963
68371L-xylose-builds acid from65328
68371D-xylose+builds acid from65327
68371D-ribose+builds acid from16988
68371L-arabinose+builds acid from30849
68371D-arabinose-builds acid from17108
68371erythritol-builds acid from17113
68371glycerol-builds acid from17754
116048nitrate-reduction17632
116048nitrite-reduction16301

metabolite production

  • @ref: 116048
  • Chebi-ID: 35581
  • metabolite: indole
  • production: no

enzymes

@refvalueactivityec
68382alpha-fucosidase-3.2.1.51
68382alpha-mannosidase-3.2.1.24
68382N-acetyl-beta-glucosaminidase-3.2.1.52
68382beta-glucosidase+3.2.1.21
68382alpha-glucosidase+3.2.1.20
68382beta-glucuronidase-3.2.1.31
68382beta-galactosidase+3.2.1.23
68382alpha-galactosidase+3.2.1.22
68382naphthol-AS-BI-phosphohydrolase-
68382acid phosphatase+3.1.3.2
68382alpha-chymotrypsin-3.4.21.1
68382trypsin-3.4.21.4
68382cystine arylamidase-3.4.11.3
68382valine arylamidase-
68382leucine arylamidase+3.4.11.1
68382lipase (C 14)-
68382esterase lipase (C 8)-
68382esterase (C 4)-
68382alkaline phosphatase-3.1.3.1
116048oxidase-
116048catalase-1.11.1.6
116048urease-3.5.1.5

fatty acid profile

  • fatty acids

    @reffatty acidpercentageECL
    65604C10:00.910
    65604C12:02.612
    65604C14:010.114
    65604C16:033.416
    65604C18:09.718
    65604C13:0 3OH/C15:1 i I/H4.714.469
    65604C13:1 at 12-131.312.931
    65604C16:1 ω9c215.774
    65604C17:0 iso 3OH1.518.161
    65604C18:1 ω9c17.217.769
    65604C18:1 ω9c DMA12.118.226
    65604C18:2 ω6,9c/C18:0 ANTE3.417.724
    65604Unidentified1.2
  • type of FA analysis: whole cell analysis
  • method/protocol: CCUG

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
116048-----+----+-++-++---

API 50CHac

@refQGLYERYDARALARARIBDXYLLXYLADOMDXGALGLUFRUMNESBERHADULINOMANSORMDMMDGNAGAMYARBESCSALCELMALLACMELSACTREINUMLZRAFAMDGLYGXLTGENTURLYXTAGDFUCLFUCDARLLARLGNT2KG5KG
8510----+++---++++/-+/----+/-++/-++/-+++++/-+++++/-+/--+---++------+--
8510----+++---+++--------+--+++-++++-+-+----+---------
8510----+++---+++--------+--++---+++-+-+---+---------+

Isolation, sampling and environmental information

isolation

@refsample type
8510intestine of adult
67770Intestine of adult
116048Human, Intestine of adult

isolation source categories

  • Cat1: #Host Body-Site
  • Cat2: #Gastrointestinal tract

taxonmaps

  • @ref: 69479
  • File name: preview.99_2430.png
  • url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_24;96_920;97_1072;98_1898;99_2430&stattab=map
  • Last taxonomy: Bifidobacterium
  • 16S sequence: LC071806
  • Sequence Identity:
  • Total samples: 97131
  • soil counts: 383
  • aquatic counts: 2518
  • animal counts: 94061
  • plant counts: 169

Safety information

risk assessment

@refpathogenicity humanbiosafety levelbiosafety level comment
8510yes, in single cases1Risk group (German classification)
1160481Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Bifidobacterium adolescentis 16S ribosomal RNAM587291477ena1680
20218Bifidobacterium adolescentis clone nru-1 16S ribosomal RNA gene, partial sequenceAF2758811451ena1680
20218Bifidobacterium adolescentis clone nru-5 16S ribosomal RNA gene, partial sequenceAF2758821448ena1680
20218Bifidobacterium adolescentis gene for 16S rRNA, partial sequence, strain: JCM 1275AB116269480ena1680
20218Bifidobacterium adolescentis strain JCM 1275 16S ribosomal RNA gene, partial sequenceGQ227713354ena1680
67770Bifidobacterium adolescentis gene for 16S ribosomal RNA, partial sequenceAB4373541520ena1680
67770Bifidobacterium adolescentis gene for 16S ribosomal RNA, partial sequence, strain: JCM 1275LC0718061243ena1680

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Bifidobacterium adolescentis ATCC 15703GCA_000010425completencbi367928
66792Bifidobacterium adolescentis ATCC 15703367928.6completepatric367928
66792Bifidobacterium adolescentis strain NCTC118141680.108wgspatric1680
66792Bifidobacterium adolescentis ATCC 15703639633010completeimg367928
67770Bifidobacterium adolescentis NCTC11814GCA_900445615contigncbi1680
66792Bifidobacterium adolescentis LMG 10502GCA_028743295completencbi1680

GC content

@refGC-contentmethod
851061.2high performance liquid chromatography (HPLC)
851058.9
6777058.9thermal denaturation, midpoint method (Tm)

Genome-based predictions

predictions

traitpredictionconfidencetraining_data
spore-formingno100no
motileno93.082no
flagellatedno95.753no
gram-positiveyes91.901no
anaerobicyes98.413yes
halophileno72.906no
spore-formingno96.22no
thermophileno92.692no
glucose-utilyes87.218no
aerobicno98.054yes
glucose-fermentyes84.637no

External links

@ref: 8510

culture collection no.: DSM 20083, ATCC 15703, CCUG 18363, NCTC 11814, JCM 1275, BCRC 14606, CCM 4987, CCUG 17359, CCUG 45213, CECT 5781, CGMCC 1.2190, CIP 64.59, KCTC 3216, LMG 10502, VTT E-981074, NCDO 2204

straininfo link

  • @ref: 71329
  • straininfo: 1234

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Metabolism9114514A new arabinofuranohydrolase from Bifidobacterium adolescentis able to remove arabinosyl residues from double-substituted xylose units in arabinoxylan.Van Laere KM, Beldman G, Voragen AGAppl Microbiol Biotechnol10.1007/s0025300509181997Bifidobacterium/*enzymology, Glycoside Hydrolases/*isolation & purification/metabolism, Magnetic Resonance Spectroscopy, Xylans/*metabolism, Xylose/*metabolismEnzymology
Enzymology9871108Alpha-galactosidase of Bifidobacterium adolescentis DSM 20083.Leder S, Hartmeier W, Marx SPCurr Microbiol10.1007/s0028499004111999Bifidobacterium/*enzymology, Hydrogen-Ion Concentration, Molecular Weight, Substrate Specificity, Temperature, alpha-Galactosidase/genetics/isolation & purification/*metabolismPhylogeny
Enzymology10570815Transglycosidase activity of Bifidobacterium adolescentis DSM 20083 alpha-galactosidase.Van Laere KM, Hartemink R, Beldman G, Pitson S, Dijkema C, Schols HA, Voragen AGAppl Microbiol Biotechnol10.1007/s0025300515791999Animals, Bacterial Proteins/chemistry/isolation & purification/*metabolism, Bifidobacterium/*enzymology, Chromatography, Galactosides/metabolism, Humans, Hydrogen-Ion Concentration, Hydrolysis, Magnetic Resonance Spectroscopy, Melibiose/metabolism, Oligosaccharides/biosynthesis/isolation & purification, Swine, Temperature, alpha-Galactosidase/chemistry/isolation & purification/*metabolismMetabolism
Enzymology10742215Characterization of a novel beta-galactosidase from Bifidobacterium adolescentis DSM 20083 active towards transgalactooligosaccharides.Van Laere KM, Abee T, Schols HA, Beldman G, Voragen AGAppl Environ Microbiol10.1128/AEM.66.4.1379-1384.20002000Bifidobacterium/*enzymology/growth & development, Culture Media, Galactose, Kinetics, Oligosaccharides/chemistry/*metabolism, Substrate Specificity, beta-Galactosidase/isolation & purification/*metabolismCultivation
Pathogenicity12406706Multiparametric flow cytometry and cell sorting for the assessment of viable, injured, and dead bifidobacterium cells during bile salt stress.Amor KB, Breeuwer P, Verbaarschot P, Rombouts FM, Akkermans AD, De Vos WM, Abee TAppl Environ Microbiol10.1128/AEM.68.11.5209-5216.20022002Bifidobacterium/cytology/*drug effects/enzymology/physiology, Bile Acids and Salts/*pharmacology, Cell Membrane Permeability/drug effects, Cell Separation, Esterases/metabolism, Flow Cytometry/*methods, Membrane Potentials/drug effects, ProbioticsStress
Enzymology12658515Cloning and characterization of two alpha-glucosidases from Bifidobacterium adolescentis DSM20083.van den Broek LA, Struijs K, Verdoes JC, Beldman G, Voragen AGAppl Microbiol Biotechnol10.1007/s00253-002-1179-12003Amino Acid Sequence, Bifidobacterium/classification/*enzymology, Cloning, Molecular, Glucosides/metabolism, Glycosylation, Hymecromone/*analogs & derivatives/metabolism, Molecular Sequence Data, Recombinant Proteins/analysis, Sequence Alignment, Substrate Specificity, alpha-Amylases/analysis/genetics, alpha-Glucosidases/*analysis/chemistry/*genetics/isolation & purificationPhylogeny
Enzymology14740189Physico-chemical and transglucosylation properties of recombinant sucrose phosphorylase from Bifidobacterium adolescentis DSM20083.van den Broek LA, van Boxtel EL, Kievit RP, Verhoef R, Beldman G, Voragen AGAppl Microbiol Biotechnol10.1007/s00253-003-1534-x2004Bifidobacterium/*enzymology/genetics/growth & development, Cloning, Molecular, Escherichia coli/genetics, Genomic Library, Glucosyltransferases/*chemistry/genetics/metabolism, Molecular Sequence Data, Recombinant Proteins/chemistry/metabolismMetabolism
Metabolism15480628beta-galactosidase from Bifidobacterium adolescentis DSM20083 prefers beta(1,4)-galactosides over lactose.Hinz SW, van den Brock LA, Beldman G, Vincken JP, Voragen AGAppl Microbiol Biotechnol10.1007/s00253-004-1745-92004Amino Acid Sequence, Bifidobacterium, Galactosides/*metabolism, Lactose/*metabolism, Molecular Sequence Data, Substrate Specificity, beta-Galactosidase/genetics/isolation & purification/*metabolismGenetics
Enzymology15650848Cloning and characterization of arabinoxylan arabinofuranohydrolase-D3 (AXHd3) from Bifidobacterium adolescentis DSM20083.van den Broek LA, Lloyd RM, Beldman G, Verdoes JC, McCleary BV, Voragen AGAppl Microbiol Biotechnol10.1007/s00253-004-1850-92005Arabinose/metabolism, Aspergillus niger/enzymology, Bifidobacterium/*enzymology/genetics, Carboxylesterase/genetics, *Cloning, Molecular, DNA, Bacterial/chemistry/genetics, Endo-1,4-beta Xylanases/genetics, Escherichia coli/genetics, Gene Expression, Glycoside Hydrolases/*genetics/metabolism, Molecular Sequence Data, Open Reading Frames, Recombinant Proteins/genetics/metabolism, Sequence Analysis, DNA, Sequence Homology, Amino Acid, Substrate Specificity, Trichoderma/enzymologyMetabolism
Metabolism16320365Increasing the transglycosylation activity of alpha-galactosidase from Bifidobacterium adolescentis DSM 20083 by site-directed mutagenesis.Hinz SW, Doeswijk-Voragen CH, Schipperus R, van den Broek LA, Vincken JP, Voragen AGBiotechnol Bioeng10.1002/bit.207132006*Amino Acid Substitution, Bacterial Proteins/genetics/*metabolism, Bifidobacterium/*enzymology/genetics, Catalytic Domain/genetics, Glycosylation, Hydrogen-Ion Concentration, Melibiose/*biosynthesis, Mutagenesis, Site-Directed, *Point Mutation, Protein Structure, Tertiary, Structure-Activity Relationship, Substrate Specificity/genetics, alpha-Galactosidase/genetics/*metabolismEnzymology
Metabolism16672507Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut.Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, Flint HJAppl Environ Microbiol10.1128/AEM.72.5.3593-3599.20062006Acetates/metabolism, Bacteria, Anaerobic/growth & development/*metabolism, Bifidobacterium/growth & development/*metabolism, Butyrates/*metabolism, Culture Media, Digestive System/*microbiology, Ecosystem, Fatty Acids/metabolism, Fructose, Humans, Lactates/metabolism, Oligosaccharides/metabolismCultivation
Metabolism18642926Assessment on the fermentability of xylooligosaccharides from rice husks by probiotic bacteria.Gullon P, Moura P, Esteves MP, Girio FM, Dominguez H, Parajo JCJ Agric Food Chem10.1021/jf800715b2008Bifidobacterium/growth & development/*metabolism, *Fermentation, Oligosaccharides/*metabolism, Oryza/*chemistry, Probiotics/*metabolism, Xylans/*metabolism
19004868Improvement of bacterial transformation efficiency using plasmid artificial modification.Yasui K, Kano Y, Tanaka K, Watanabe K, Shimizu-Kadota M, Yoshikawa H, Suzuki TNucleic Acids Res10.1093/nar/gkn8842008Bifidobacterium/genetics, DNA Modification Methylases/genetics, Escherichia coli/genetics, Genetic Vectors, Plasmids/*genetics, *Transformation, Bacterial
Phylogeny19502759Intra-species diversity between seven Bifidobacterium adolescentis strains identified by genome-wide tiling array analysis.Yasui K, Tabata M, Yamada S, Abe T, Ikemura T, Osawa R, Suzuki TBiosci Biotechnol Biochem10.1271/bbb.808432009Bifidobacterium/*classification/genetics, *Genome, Bacterial, Oligonucleotide Array Sequence Analysis, Species SpecificityGenetics
Metabolism19694435In vitro fermentation of arabinoxylan-derived carbohydrates by bifidobacteria and mixed fecal microbiota.Pastell H, Westermann P, Meyer AS, Tuomainen P, Tenkanen MJ Agric Food Chem10.1021/jf901397b2009Arabinose/metabolism, Bifidobacterium/genetics/growth & development/*metabolism, DNA, Bacterial/analysis, Feces/*microbiology, *Fermentation, Humans, Hydrogen-Ion Concentration, Oligosaccharides/*metabolism, Species Specificity, Xylans/*metabolism, Xylose/metabolismPathogenicity
Phylogeny20081020Bifidobacterium stercoris sp. nov., isolated from human faeces.Kim MS, Roh SW, Bae JWInt J Syst Evol Microbiol10.1099/ijs.0.019943-02010Adult, Aldehyde-Lyases/metabolism, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification/genetics/isolation & purification, Chaperonin 60/genetics, DNA, Bacterial/genetics, Fatty Acids/chemistry, Feces/*microbiology, Humans, Male, Molecular Sequence Data, Nucleic Acid Hybridization, *Phylogeny, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNAPathogenicity
20380746Characterization of recombinant beta-fructofuranosidase from Bifidobacterium adolescentis G1.Omori T, Ueno K, Muramatsu K, Kikuchi M, Onodera S, Shiomi NChem Cent J10.1186/1752-153X-4-92010
Metabolism21317917Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity?Uibo R, Panarina M, Teesalu K, Talja I, Sepp E, Utt M, Mikelsaar M, Heilman K, Uibo O, Vorobjova TCell Mol Immunol10.1038/cmi.2010.662011Adolescent, Animals, Antibodies, Bacterial/immunology, Bacterial Proteins/immunology, Bifidobacterium/immunology, Cattle, Celiac Disease/*complications/*immunology/microbiology/pathology, Child, Child, Preschool, Diabetes Mellitus, Type 1/*complications/*immunology/microbiology/pathology, Female, Forkhead Transcription Factors/genetics/metabolism, GTP-Binding Proteins/genetics/metabolism, Gene Expression Regulation, Gliadin/immunology, Humans, Immunity/*immunology, Immunoglobulin A/immunology, Immunoglobulin G/immunology, Infant, Intestinal Mucosa/enzymology/pathology, Intestines/*immunology/*pathology, Lactoglobulins/immunology, Male, Membrane Proteins/genetics/metabolism, Phosphoproteins/genetics/metabolism, Protein Glutamine gamma Glutamyltransferase 2, RNA, Messenger/genetics/metabolism, Transglutaminases/genetics/metabolism, Zonula Occludens-1 ProteinPathogenicity
Metabolism21815100Plasmid artificial modification: a novel method for efficient DNA transfer into bacteria.Suzuki T, Yasui KMethods Mol Biol10.1007/978-1-61779-197-0_182011Bifidobacterium/*genetics, DNA Modification Methylases/genetics/*metabolism, DNA, Bacterial/*genetics, Electroporation, Escherichia coli/cytology/*genetics, Genetic Vectors/*genetics, Plasmids/*genetics, *Transformation, Bacterial
Enzymology22534302Cloning and characterization of ginsenoside Ra1-hydrolyzing beta-D-xylosidase from Bifidobacterium breve K-110.Hyun YJ, Kim B, Kim DHJ Microbiol Biotechnol10.4014/jmb.1110.100012012Amino Acid Sequence, Bacterial Proteins/*chemistry/*genetics/metabolism, Base Sequence, Bifidobacterium/chemistry/*enzymology/genetics/isolation & purification, *Cloning, Molecular, Feces/microbiology, Ginsenosides/*metabolism, Humans, Kinetics, Molecular Sequence Data, Molecular Weight, Xylosidases/*chemistry/*genetics/metabolismMetabolism
Genetics22639142A targeted gene knockout method using a newly constructed temperature-sensitive plasmid mediated homologous recombination in Bifidobacterium longum.Sakaguchi K, He J, Tani S, Kano Y, Suzuki TAppl Microbiol Biotechnol10.1007/s00253-012-4090-42012Bacterial Proteins/genetics, Bifidobacterium/*genetics, DNA Replication, Gene Knockout Techniques/*methods, Genes, Bacterial, Genetic Vectors, Homologous Recombination, Mutation, Missense, Plasmids, Temperature
Metabolism23822770Xylooligosaccharides from hardwood and cereal xylans produced by a thermostable xylanase as carbon sources for Lactobacillus brevis and Bifidobacterium adolescentis.Falck P, Precha-Atsawanan S, Grey C, Immerzeel P, Stalbrand H, Adlercreutz P, Karlsson ENJ Agric Food Chem10.1021/jf401249g2013Bacterial Proteins/*chemistry, Betula/*chemistry/metabolism, Bifidobacterium/growth & development/*metabolism, Biocatalysis, Carbon/chemistry/metabolism, Endo-1,4-beta Xylanases/*chemistry, Enzyme Stability, Glucuronates/chemistry/*metabolism, Hydrolysis, Lactobacillus brevis/growth & development/*metabolism, Oligosaccharides/chemistry/*metabolism, Prebiotics/analysis, Rhodothermus/*enzymology, Secale/*chemistry/metabolism, Wood/chemistry/metabolism, Xylans/*chemistry/metabolismEnzymology
Metabolism23924734Motif-guided identification of a glycoside hydrolase family 1 alpha-L-arabinofuranosidase in Bifidobacterium adolescentis.Suzuki H, Murakami A, Yoshida KBiosci Biotechnol Biochem10.1271/bbb.1302792013Amino Acid Motifs/*genetics, Bifidobacterium/*enzymology, Genome, Bacterial, Glycoside Hydrolases/chemistry/*metabolism, Glycosides/metabolism, Hydrolysis, Protein Structure, Tertiary, Substrate Specificity, Xylans/metabolismGenetics
Phylogeny24187022Reclassification of Bifidobacterium stercoris Kim et al. 2010 as a later heterotypic synonym of Bifidobacterium adolescentis.Killer J, Sedlacek I, Rada V, Havlik J, Kopecny JInt J Syst Evol Microbiol10.1099/ijs.0.054957-02013Aldehyde-Lyases/genetics, Bacterial Typing Techniques, Bifidobacterium/*classification/genetics, DNA Gyrase/genetics, DNA, Bacterial/genetics, DNA-Directed RNA Polymerases/genetics, Molecular Sequence Data, Multilocus Sequence Typing, Nucleic Acid Hybridization, Peptide Elongation Factor G/genetics, Phenotype, *Phylogeny, RNA, Ribosomal, 16S/genetics, Ribosomal Proteins/genetics, Sequence Analysis, DNAGenetics
Pathogenicity24741589Antibodies to Lactobacilli and Bifidobacteria in young children with different propensity to develop islet autoimmunity.Talja I, Kubo AL, Veijola R, Knip M, Simell O, Ilonen J, Vaha-Makila M, Sepp E, Mikelsaar M, Utt M, Uibo RJ Immunol Res10.1155/2014/3259382014Antibodies, Bacterial/*immunology, *Autoimmunity, Bacterial Proteins/immunology, Bifidobacterium/*immunology, Child, Child, Preschool, Diabetes Mellitus, Type 1/immunology, Female, Humans, Immunoglobulin A/immunology, Immunoglobulin G/immunology, Immunoglobulin M/immunology, Intestines/immunology/microbiology, Islets of Langerhans/*immunology, Lactobacillus/*immunology, Male
Phylogeny24944342Bifidobacterium faecale sp. nov., isolated from human faeces.Choi JH, Lee KM, Lee MK, Cha CJ, Kim GBInt J Syst Evol Microbiol10.1099/ijs.0.063479-02014Aldehyde-Lyases/metabolism, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification/genetics/isolation & purification, Chaperonin 60/genetics, DNA, Bacterial/genetics, Fatty Acids/chemistry, Feces/*microbiology, Humans, Infant, Newborn, Molecular Sequence Data, Nucleic Acid Hybridization, *Phylogeny, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNAPathogenicity
Pathogenicity25794720Enzymatic production of HMO mimics by the sialylation of galacto-oligosaccharides.Wang Y, Jiang K, Ma H, Zeng W, Wang PG, Yao N, Han W, Cheng J, Wang WFood Chem10.1016/j.foodchem.2015.02.0642015Health Maintenance Organizations, Humans, Milk, Human, Oligosaccharides/*chemistry, Polysaccharides/*chemistry, PrebioticsBiotechnology
Metabolism26297820Biochemical identification of the catalytic residues of a glycoside hydrolase family 120 beta-xylosidase, involved in xylooligosaccharide metabolisation by gut bacteria.Cecchini DA, Faure R, Laville E, Potocki-Veronese GFEBS Lett10.1016/j.febslet.2015.08.0122015Bacterial Proteins/chemistry/genetics/*metabolism, Bifidobacterium/genetics/*metabolism, Binding Sites/genetics, Catalytic Domain, Glucuronates/chemistry/*metabolism, Humans, Hydrogen-Ion Concentration, Hydrolysis, Intestines/microbiology, Kinetics, Magnetic Resonance Spectroscopy, Models, Molecular, Molecular Structure, Mutation, Oligosaccharides/chemistry/*metabolism, Protein Structure, Tertiary, Substrate Specificity, Xylosidases/chemistry/genetics/*metabolismPathogenicity
Metabolism27692648Development of stable isotope dilution assays for the quantitation of intra- and extracellular folate patterns of Bifidobacterium adolescentis.Kopp M, Durr K, Steigleder M, Clavel T, Rychlik MJ Chromatogr A10.1016/j.chroma.2016.09.0482016Bifidobacterium adolescentis/*metabolism, Biological Assay, Chromatography, Liquid, Deuterium, Folic Acid/analogs & derivatives/metabolism, Indicator Dilution Techniques, Reproducibility of Results, Tandem Mass Spectrometry, Tetrahydrofolates/*metabolismProteome
28377750Measurements of Intra- and Extra-Cellular 5-Methyltetrahydrofolate Indicate that Bifidobacterium Adolescentis DSM 20083(T) and Bifidobacterium Pseudocatenulatum DSM 20438(T) Do Not Actively Excrete 5-Methyltetrahydrofolate In vitro.Kopp M, Durr K, Steigleder M, Clavel T, Rychlik MFront Microbiol10.3389/fmicb.2017.004452017
Pathogenicity28432676Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): Probiotics Able to Block the In Vitro Adherence of Rotavirus in MA104 Cells.Fernandez-Duarte KP, Olaya-Galan NN, Salas-Cardenas SP, Lopez-Rozo J, Gutierrez-Fernandez MFProbiotics Antimicrob Proteins10.1007/s12602-017-9277-72018Antiviral Agents/*pharmacology, Bifidobacterium adolescentis/*physiology, Cell Line, Gastroenteritis/prevention & control/virology, Humans, Lactobacillus casei/chemistry/*physiology, Probiotics/*pharmacology, Rotavirus/*drug effects/physiology, Rotavirus Infections/prevention & control/*virology, Virus Attachment/*drug effects
Metabolism29337072Valorization of Brewer's spent grain to prebiotic oligosaccharide: Production, xylanase catalyzed hydrolysis, in-vitro evaluation with probiotic strains and in a batch human fecal fermentation model.Sajib M, Falck P, Sardari RRR, Mathew S, Grey C, Karlsson EN, Adlercreutz PJ Biotechnol10.1016/j.jbiotec.2018.01.0052018Batch Cell Culture Techniques/*methods, *Beer, *Biocatalysis, Chromatography, Ion Exchange, Endo-1,4-beta Xylanases/*metabolism, Fatty Acids/metabolism, Feces/chemistry, Fermentation/*drug effects, Gases/metabolism, Hordeum, Humans, Hydrogen-Ion Concentration, Hydrolysis, Models, Biological, Oligosaccharides/*pharmacology, *Prebiotics, Probiotics/*pharmacology, Waste Products, Xylans/isolation & purificationPathogenicity
29633635Prophylactic Bifidobacterium adolescentis ATTCC 15703 supplementation reduces partially allergic airway disease in Balb/c but not in C57BL/6 mice.Casaro MC, Crisma AR, Vieira AT, Silva GHM, Mendes E, Ribeiro WR, Martins FS, Ferreira CMBenef Microbes10.3920/BM2017.00732018Administration, Oral, Animals, Asthma/*prevention & control, Bifidobacterium adolescentis/*growth & development, Disease Models, Animal, Eosinophils/immunology, Mice, Inbred BALB C, Mice, Inbred C57BL, Probiotics/*administration & dosage, Respiratory System/*pathology, Treatment Outcome
29881432Promoting Probiotics Survival by Microencapsualtion with Hylon Starch and Genipin Cross-linked Coatings in Simulated Gastro-intestinal Condition and Heat Treatment.Khosravi Zanjani MA, Ehsani MR, Ghiassi Tarzi B, Sharifan AIran J Pharm Res2018
Pathogenicity30465831Polysaccharide fractions from Fortunella margarita affect proliferation of Bifidobacterium adolescentis ATCC 15703 and undergo structural changes following fermentation.Chen P, You Q, Li X, Chang Q, Zhang Y, Zheng B, Hu X, Zeng HInt J Biol Macromol10.1016/j.ijbiomac.2018.11.1632018Bifidobacterium adolescentis/drug effects/*growth & development, Fatty Acids/biosynthesis, Fermentation/*drug effects, Hydrogen-Ion Concentration, Lactic Acid/biosynthesis, Molecular Conformation, Molecular Weight, Polysaccharides/*chemistry/metabolism/*pharmacology, Rutaceae/*chemistryMetabolism
Metabolism30890726Estimation of microbial phosphate-accumulation abilities.Anand A, Aoyagi HSci Rep10.1038/s41598-018-37752-82019Bifidobacterium adolescentis/*drug effects/metabolism, Cell-Free System, Gastrointestinal Microbiome/drug effects, Humans, Hyperphosphatemia/drug therapy/*metabolism/pathology, Lactobacillus casei/*drug effects/metabolism, Phosphate-Binding Proteins/metabolism, Phosphates/adverse effects/*metabolism, Probiotics/isolation & purification/metabolism, Renal Dialysis/adverse effectsPathogenicity
Enzymology31134431A quantitative model of Bacillus cereus ATCC 9634 growth inhibition by bifidobacteria for synbiotic effect evaluation.Karetkin BA, Guseva EV, Evdokimova SA, Mishchenko AS, Khabibulina NV, Grosheva VD, Menshutina NV, Panfilov VIWorld J Microbiol Biotechnol10.1007/s11274-019-2665-22019Acetic Acid, Antibiosis, Bacillus cereus/drug effects/*growth & development, Bacteriocins/isolation & purification, Bifidobacterium/*physiology, Coculture Techniques, Fatty Acids, Volatile/pharmacology, Fermentation, Food Contamination, Hydrogen-Ion Concentration, Inulin, Kinetics, Lactic Acid, Microbial Sensitivity Tests, Prebiotics, Probiotics, Propionates, *SynbioticsPathogenicity
Transcriptome31762999Combining of transcriptome and metabolome analyses for understanding the utilization and metabolic pathways of Xylo-oligosaccharide in Bifidobacterium adolescentis ATCC 15703.Yang J, Tang Q, Xu L, Li Z, Ma Y, Yao DFood Sci Nutr10.1002/fsn3.11942019
Phylogeny31792245A High Throughput Isolation Method for Phosphate-Accumulating Organisms.Anand A, Aoyagi HSci Rep10.1038/s41598-019-53429-22019Bifidobacterium adolescentis/isolation & purification/*metabolism, Cell Culture Techniques, Centrifugation, Density Gradient, Humans, Hyperphosphatemia/metabolism/therapy, Lactobacillus casei/isolation & purification/*metabolism, Phosphates/isolation & purification/*metabolism, Probiotics/isolation & purification/*metabolismMetabolism
34354509Characterization of a GH36 beta-L-Arabinopyranosidase in Bifidobacterium adolescentis.Sasaki Y, Togo N, Kitahara K, Fujita KJ Appl Glycosci (1999)10.5458/jag.jag.JAG-2018_0012018
35464910Study on the Biochemical Characterization and Selectivity of Three beta-Glucosidases From Bifidobacterium adolescentis ATCC15703.Hu Y, Zhai L, Hong H, Shi Z, Zhao J, Liu DFront Microbiol10.3389/fmicb.2022.8600142022
35630373A Study and Modeling of Bifidobacterium and Bacillus Coculture Continuous Fermentation under Distal Intestine Simulated Conditions.Evdokimova SA, Karetkin BA, Guseva EV, Gordienko MG, Khabibulina NV, Panfilov VI, Menshutina NV, Gradova NBMicroorganisms10.3390/microorganisms100509292022

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
8510Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 20083)https://www.dsmz.de/collection/catalogue/details/culture/DSM-20083
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
32787Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/10164
65604Curators of the CCUGCulture Collection University of Gothenburg (CCUG) (CCUG 18363)https://www.ccug.se/strain?id=18363
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
66794Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg10.1093/nar/gkaa1025BRENDA, the ELIXIR core data resource in 2021: new developments and updatesNucleic Acids Res. 49: D498-D508 202033211880
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68371Automatically annotated from API 50CH acid
68382Automatically annotated from API zym
69479João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.https://microbeatlas.org/MicrobeAtlas 1.0 beta
69480Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesPredictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
69481Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch10.21203/rs.3.rs-2527258/v1Predictions based on the model GenomeNet Sporulation v. 1
71329Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID1234.1StrainInfo: A central database for resolving microbial strain identifiers
116048Curators of the CIPCollection of Institut Pasteur (CIP 64.59)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2064.59